Parnax Lab

Parnax Lab OCF Margin

The Operating Cash Flow Margin of Parnax Lab (506128.BO) as of Nov 14, 2026 is 17.21 %. In the previous year, Operating Cash Flow Margin was 8.41 % — a change of 104.50% (higher).

OCF Margin

17.21 %

YoY

104.50%

Last updated:

Operating Cash Flow Margin of Parnax Lab is 2025 17.21 % . Operating Cash Flow Margin of Parnax Lab was 2024 8.41 % . It decreases by 104.50% higher compared to the previous year.

The Parnax Lab OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
12.21 INR
Jan 1, 2019
8.01 INR
Jan 1, 2020
9.18 INR
Jan 1, 2021
7.01 INR
Jan 1, 2022
5.24 INR
Jan 1, 2023
12.48 INR
Jan 1, 2024
8.41 INR
Jan 1, 2025
17.21 INR
The Parnax Lab OCF Margin history
YEAROCF MarginYoY
17.21 %+104.50%
8.41 %-32.56%
12.48 %+138.00%
5.24 %-25.17%
7.01 %-23.65%
9.18 %+14.52%
8.01 %-34.39%
12.21 %+0.36%
12.17 %+148.54%
4.90 %-2,107.25%
-0.24 %+13.86%
-0.21 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Parnax Lab Stock analysis

What does Parnax Lab do? Parnax Lab Ltd. generates revenue through manufacturing and exporting pharmaceutical formulations, including cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, geriatric special formulations, highly viscous products, and suspensions. The company trades pharmaceuticals and medicinal products, focusing on high-volume oral formulations for diverse consumer segments. Naxpar Pharma Private Limited serves as its subsidiary in these operations. The firm's primary customers are likely healthcare providers, pharmacies, and distributors within the pharmaceutical industry, though specific buyer details are not disclosed. Parnax Lab Ltd. operates through the pharmaceutical formulations segment, emphasizing export-driven manufacturing and trading activities. Its product portfolio targets various health needs, from pediatric to geriatric care, with a strong focus on oral delivery systems. Parnax Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Parnax Lab stock

Operating Cash Flow Margin of Parnax Lab is 17.21 % in 2025.

Operating Cash Flow Margin of Parnax Lab changed from 8.41 % to 17.21 %, representing a 104.50% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Parnax Lab since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Parnax Lab with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Parnax Lab

All Key Metrics — Parnax Lab